Growth Metrics

Novartis Ag (NVS) Gross Margin (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -154.31 Mn
Mar 31, 2023 153.60 Mn
Dec 31, 2022 720,115.00
Sep 30, 2022 56.00
Jun 30, 2022 -1,337.00
Mar 31, 2022 1,320.00
Dec 31, 2021 -926.00
Sep 30, 2021 935.00
Jun 30, 2021 -504.00
Mar 31, 2021 -709,378.00
Dec 31, 2020 709,120.00
Sep 30, 2020 -6,512.00
Jun 30, 2020 -137.00
Mar 31, 2019 -37,659.00
Dec 31, 2018 17,023.00
Sep 30, 2018 18,311.00
Jun 30, 2018 2,464.00
Mar 31, 2018 -39,839.00
Dec 31, 2017 -2,687.00
Sep 30, 2017 -383,455.00
Dec 31, 2016 -29,600.00
Sep 30, 2016 -9,536.00
Jun 30, 2016 10,181.00
Mar 31, 2016 -114,401.00
Dec 31, 2015 99,968.00
Mar 31, 2015 39,444.00
Dec 31, 2014 -1,568.00
Jun 30, 2009 7.50 Mn